PressAugust 17, 2023 Novel Combination of Oral Ketamine and Aspirin Is Safe Form of Pain Medication after Total Knee Replacement Surgery
PressAugust 17, 2023 COMPASS Pathways Announces Up to $285 Million Private Placement Financing Joined by Leading Healthcare Investors
BlogAugust 17, 2023 Mind Cure Health Inc. (To Be Renamed LNG Energy Group Corp.) Announces Completion of Business Combination Transaction
PressAugust 15, 2023 Filament Health and Nasdq-Listed SPAC Jupiter Acquisition Corp. Announce Filing of SEC Registration Statement
PressAugust 14, 2023 Clearmind Medicine Announces Collaboration with CTS Ltd., a Leading Pharmaceutical and Consumer Products Company
PressAugust 14, 2023 NRx Pharmaceuticals Announces the Licensure of a US Patent to Support Use of NRX-101™ for Chronic Pain
PressAugust 11, 2023 Apex Labs announces the appointment of Chief Medical Officer & Chief Commercial Officer
PressAugust 11, 2023 atai Life Sciences Reports Second Quarter 2023 Financial Results and Operational Highlights, and Announces Clinical Data from the Phase 1 Study of DMX-1002 (Ibogaine)
PressAugust 11, 2023 Enthea Reports Clinical Results from First Year of Psychedelic Healthcare Benefit for Employees of Leading California-Based Soap Company
PressAugust 10, 2023 Numinus to Participate in a Water Tower Research Fireside Chat on Thursday, August 17, 2023
PressAugust 10, 2023 atai Life Sciences Announces Results from the Phase 1 IV-to-Subcutaneous Bridging Study of PCN-101 (R-Ketamine)
PressAugust 8, 2023 Bright Minds Biosciences Announces Positive qEEG (Quantitative Electroencephalogram) Data from its First-in-Human Phase 1 Study of Lead Compound, BMB-101
PressAugust 8, 2023 Silo Pharma Reaches Positive Milestone with Nasal Formulation of SPC-15 For Anxiety, PTSD, and Stress-Related Disorders
